Adjuvant Nivolumab Beneficial in Esophageal, GE Junction Cancer

Disease - free survival significantly longer in patients with resected esophageal, gastroesophageal junction cancer
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Pharmacy, Journal, Source Type: news